SIGHT SCIENCES INC's ticker is and the CUSIP is 82657M105. A total of 66 filers reported holding SIGHT SCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,746 | -54.8% | 26,334 | +11.1% | 0.00% | – |
| Q2 2023 | $196,195 | -15.8% | 23,695 | -11.1% | 0.00% | -100.0% |
| Q1 2023 | $232,947 | -9.0% | 26,653 | +27.2% | 0.00% | 0.0% |
| Q4 2022 | $255,848 | +95.3% | 20,954 | +1.8% | 0.00% | – |
| Q3 2022 | $131,000 | -29.6% | 20,574 | -0.8% | 0.00% | – |
| Q2 2022 | $186,000 | – | 20,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KCK LTD. | 4,776,232 | $42,938,000 | 60.33% |
| Sio Capital Management, LLC | 724,944 | $6,517,000 | 2.45% |
| D1 Capital Partners L.P. | 5,852,036 | $52,610,000 | 1.25% |
| PFM Health Sciences, LP | 776,281 | $6,979,000 | 0.27% |
| RTW INVESTMENTS, LP | 997,099 | $8,964,000 | 0.23% |
| ArrowMark Colorado Holdings LLC | 1,587,305 | $14,270,000 | 0.16% |
| Jackson Square Partners, LLC | 595,051 | $5,349,000 | 0.12% |
| Atom Investors LP | 11,181 | $101,000 | 0.04% |
| Bellevue Group AG | 294,606 | $2,649,000 | 0.04% |
| Orbimed Advisors | 200,000 | $1,798,000 | 0.03% |